Prednisolone, platelet-activating factor receptor antagonist, or superoxide dismutase reduced leukocyte entrapment induced by interferon alpha in retinal microcirculation

Investigative Ophthalmology and Visual Science

Volumn 38, Issue 5, 1997, Pages 811-816

  Nishiwaki, Hirokazu ^a   Ogura, Yuichiro ^a   Miyamoto, Kazuaki ^a   Hiroshiba, Naoko ^a   Hamada, Muneo ^a   Honda, Yoshihito ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

acridine orange; digital fluorography; IFN alpha; IFN induced retinopathy; leukocyte adherence; leukocyte entrapment

Indexed keywords

2 [N (2 METHOXY 3 OCTADECYLCARBAMOYLOXYPROPOXYCARBONYL)ACETAMIDOMETHYL] 1 ETHYLPYRIDINIUM CHLORIDE; ALPHA INTERFERON; PREDNISOLONE; RECOMBINANT ALPHA2B INTERFERON; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ADHERENCE; MALE; NONHUMAN; PRIORITY JOURNAL; RETINA ARTERY OCCLUSION; RETINA BLOOD FLOW; RETINA CAPILLARY; SUBRETINAL NEOVASCULARIZATION; VASCULAR ENDOTHELIUM;

ACRIDINE ORANGE; ANIMALS; ANTIVIRAL AGENTS; CAPILLARIES; CELL ADHESION; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; FLUORESCEIN ANGIOGRAPHY; FLUORESCENT DYES; FLUOROPHOTOMETRY; GLUCOCORTICOIDS; LEUKOCYTES; MICROCIRCULATION; PLATELET ACTIVATING FACTOR; PREDNISOLONE; PYRIDINIUM COMPOUNDS; RATS; RETINAL VESSELS; SUPEROXIDE DISMUTASE;

EID: 0030901629     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Fung WE. Interferon alpha 2a for treatment of age-related macular degeneration [letter]. Am J Ophthalmol. 1991;112:349-350.
2. Thomas MA, Ibanez HE. Interferon alfa-2a in the treatment of subfoveal neovascularization. Am J Ophthalmol. 1993;115:563-568.
3. Chan CK, Kempin SJ, Noble SK, Palmer GA. The treatment of choroidal neovascular membranes by alpha interferon. Ophthalmology. 1994:101:289-300.
4. Guyer DR, Tiedeman J, Yannuzzi LA, et al. Interferon-associated retinopathy. Arch Ophthalmol. 1993:111:350-356.
5. Ikebe T, Nakatsuka K, Goto M, Sakai Y. A case of retinopathy induced by intravenous administration of interferon. Folia Ophthalmol Jpn. 1990;41:2291-2296.
6. Chuman T, Nao-i N, Sawada A, Kawano T, Shigehira M. Interferon-induced retinal changes. Nippon Ganka Gakkai Zasshi. 1994;98:616-621.
7. Nishiwaki H, Ogura Y, Miyamoto K, Matsuda N, Honda Y. Interferon alfa induces leukocyte capillary plugging in rat retinal microcirculation. Arch Ophthalmol. 1996,114:726-730.
8. Baron S, Tyring SK, Fleischmann WR, et al. The interferons. JAMA. 1991;266:1375-1383.
9. Jett JR, Mantovani A, Herberman RB. Augmentation of human monocyte-mediated cytolysis by Interferon. Cell Immunol. 1980;54:413-416.
10. Dean RT, Virelizier JL. Interferon as a macrophage-activating factor. I. Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals. Clin Exp Immunol. 1983;51:501-510.
11. Jarstrand C, Einhorn S. Effect of Interferon on human neutrophilic granulocytes. Cancer Immunol Immunother. 1983;16:123-126.
12. Seow WK, Thong YH. Augmentation of human polymorphonuclear leukocyte adherence by interferon. Int Arch Allergy Appl Immunol. 1986;79:305-311.
13. Schmid-Scḧonbein GW, Skalak R, Simon SI, Engler R. The interaction between leukocytes and endothelium in vivo. Ann N Y Acad Sci. 1987;516:348-361.
14. Sutton DW, Schmid-Scḧonbein GW. Elevation of organ resistance due to leukocyte perfusion. Am J Physiol. 1992;262:1646-1650.
15. Harris AG, Skalak TC. Effects of leukocyte activation on capillary hemodynamics in skeletal muscle. Am J Physiol. 1993;264:H909-H916.
16. Fantone, JG, Ward PA. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol. 1982;107:397-418.
17. Tauber AI, Babior BM. Neutrophil oxygen reduction: The enzymes and the products. Adv Free Radical Biol Med. 1985;1:265-307.
18. Baggiolini M. The enzymes of the granules of polymorphonuclear leukocytes and their function. Enzyme. 1972;13:131-160.
19. Harlan JM. Leukocyte-endothelial interactions. Blood. 1985;65:513-525.
20. Dyer EL, Snapper JR. Role of circulating granulocytes in sheep lung injury produced by phorbol myristate acetate. J Appl Physiol 1986;60:576-589.
21. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 1983;67:1016-1023.
22. Barroso-Aranda J, Schmid-Schönbein GW, Zweifach BW, Engler RL. Granulocytes and no-reflow phenomenon in irreversible hemorrhagic shock. Circ Res. 1988;63:437-447.
23. Nishiwaki H, Ogura Y, Kimura H, Kiryu J, Honda Y. Quantitative evaluation of leukocyte dynamics in retinal microcirculation. Invest Ophthalmol Vis Sci. 1995;36:123-130.
24. Kimura H, Kiryu J, Nishiwaki H, Ogura Y. A new fluorescent imaging procedure in vivo for evaluation of the retinal microcirculation in rats. Curr Eye Res. 1995;14:223-228.
25. Nishiwaki H, Ogura Y, Kimura H, Kiryu J, Miyamoto K, Matsuda N. Visualization and quantitative analysis of leukocyte dynamics in retinal microcirculation of rats. Invest Ophthalmol Vis Sci. 1996;37:1341-1347.
26. Chorvath B, Sedlak J, Duraj J, et al. Biochemical and immunological phenotype alterations in human monoblastoid cell line U-937 induced by physiological (interferon-alpha, retinoic acid) and nonphysiological (phorbol ester) inducers. Neoplasma. 1990;37:317-331.
27. Pak CB, Imanishi J, Kishida T, Matsuo A. Increased nitroblue tetrazolium dye reduction by human neutrophils stimulated by interferon in vitro. Microbiol Immunol. 1980;24:717-723.
28. Deblandre GA, Leo O, Huez GA, Wathelet MG. CD69 expressed on Daudi cells in response to interferon-alpha. Cytokine. 1992;4:36-43.
29. Evans SS, Collea RP, Appenheimer MM, Gollnick SO. Interferon-alpha induces the expression of the L-selectin homing receptor in human B lymphoid cells. J Cell Biol. 1993;123:1889-1898.
30. Higuchi H, Yan HJ, Kurose I, et al. Alpha-interferon induced microvascular alterations in rat mesentery. Microcirculation Ann. 1994;10:71-72.
31. Bagge U, Amundson B, Lauritzen C. White blood cell deformability and plugging of skeletal muscle capillaries in hemorrhagic shock. Acta Physiol Scand. 1980;180:159-163.
32. Schmid-Schönbein GW, Seiffge D, DeLano FA, Shen K, Zweifach BW. Leukocyte counts and activation in spontaneously hypertensive and normotensive rats. Hypertension. 1991;17:323-330.
33. Engler RL, Dahlgren MD, Morris DD, Peterson MA, Schmid-Schönbein GW. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 1986;251:H314-H322.
34. Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU. Clinical toxicity of interferons in cancer patients: A review. J Clin Oncol. 1986;4:234-243.
35. Boogaerts MA, Yamada O, Jacob HS, Moldow CF. Enhancement of granulocyte-endothelial cell adherence and granulocyte-induced cytotoxicity by platelet release products. Proc Natl Acad Sci USA. 1982;79:7019-7023.
36. Hoover RL, Karnovsky MJ, Austen KF, Corey EJ, Lewis RA. Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion. Proc Natl Acad Sci USA. 1984;81:2191-2194.
37. Prescott SM, Zimmerman GA, McIntyre TM. Platelet-activating factor. J Biol Chem. 1990;265:17381-17384.
38. Suzuki M, Asako H, Kubes P, Jennings S, Grisham M, Granger DN. Neutrophil-derived oxidants promote leukocyte adherence in postcapillary venules. Microvasc Res. 1991;42:125-138.
39. Kubes P, Ibbotson G, Russell J, Wallace JL, Granger DN. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Am J Physiol. 1990;259:G300-G305.
40. Yedgar S, Vlodavsky I, Panet A, Reisfeld N, Eldor A. Interferon enhances phospholipase A2 activity in bovine aortic endothelial cells. Eicosanoids. 1990;3:225-229.
41. Drath DB, Karnovsky ML. Superoxide production by phagocytic leukocytes. J Exp Med. 1975;141:257-261.
42. Kubes P, Suzuki M, Granger DN. Modulation of PAF-induced leukocyte adherence and increased microvascular permeability. Am J Physiol. 1990;259:G859-G864.
43. Suzuki M, Inauen W, Kvietys PR, et al. Superoxide mediates reperfusion-induced leukocyte-endothelial cell interactions. Am J Physiol. 1989;257:H1740-H1745.
44. Gillespie D, Carter WA, Species specificity of interferon. Tex Rep Biol Med. 1982;41:37-42.
45. Bocci V, Pessina GP, Pacini A, et al. Pharmacokinetics of human lymphoblastoid interferon in rabbits. Gen Pharmacol. 1985;16:277-279.
46. Billiau A, Heremans H, Ververken D, Van Damme J, Carton H, De Somer P. Tissue distribution of human interferons after exogeneous administration in rabbits, monkeys, and mice. Arch Virol. 1981;68:19-25.
47. 125I]-labeled human leukocyte-derived alpha interferon in the rat. J Interferon Res. 1985;5:121-127.